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Abstract
Malaria in pregnancy threatens birth outcomes and the health of women and their newborns.
This is also the case in low transmission areas, such as Colombia, where Plasmodium vivax
is the dominant parasite species. Within the Colombian health system, which underwent
major reforms in the 90s, malaria treatment is provided free of charge to patients. However,
patients still incur costs, such as transportation and value of time lost due to the disease. We
estimated such costs among 40 pregnant women with clinical malaria (30% Plasmodium fal-
ciparum, 70% Plasmodium vivax) in the municipality of Tierralta, Northern Colombia. In a
cross-sectional study, women were interviewed after an outpatient or inpatient laboratory
confirmed malaria episode. Women were asked to report all types of cost incurred before
(including prevention), during and immediately after the contact with the health facility.
Median total cost was over 16US$ for an outpatient visit, rising to nearly 30US$ if other treat-
ments were sought before reaching the health facility. Median total inpatient cost was 26US
$ or 54US$ depending on whether costs incurred prior to admission were excluded or
included. For both outpatients and inpatients, direct costs were largely due to transportation
and indirect costs constituted the largest share of total costs. Estimated costs are likely to
represent only one of the constraints that women face when seeking treatment in an area
characterized, at the time of the study, by armed conflict, displacement, and high vulnerabil-
ity of indigenous women, the group at highest risk of malaria. Importantly, the Colombian
peace process, which culminated with the cease-fire in August 2016, may have a positive
impact on achieving universal access to healthcare in conflict areas. The current study can
inform malaria elimination initiatives in Colombia.
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Author summary
Malaria in pregnancy is a harsh and undesirable illness and is the cause of adverse effects
on birth outcomes and on the health of women and newborns. Despite the low transmis-
sion, the predominance of Plasmodium vivax over Plasmodium falciparum and free treat-
ment, estimated costs incurred by pregnant women seeking malaria care in an endemic
area of Northern Colombia are considerable. Importantly, these costs are likely to repre-
sent only one of the constraints that women face when seeking treatment in an area char-
acterized, at the time of the study, by armed conflict, displacement, and high vulnerability
of indigenous women, the group at highest risk of malaria in the area. Important advances
may result from the current peace process, potentially able to support the efforts made
since the 90s to reform the health system towards achieving universal health coverage.
Within this context, the current study can inform malaria elimination initiatives in
Colombia.
Introduction
Malaria is a harsh, undesirable and life-threatening disease and, if experienced during preg-
nancy, can cause adverse effects on birth outcomes and on the health of women and newborns
[1]. Such effects encompass long term disabilities and, at the aggregate level, are likely to slow
down considerably the economic development of endemic areas [2–4]. In the short term, a
malaria in pregnancy (MiP) episode may produce a considerable shock to households’ budgets
[5].
In low endemicity areas, including Colombia where P. vivax predominates, little informa-
tion is available on the epidemiology and the socio-economic aspects of malaria. In Colombia,
few studies have examined the socio-economic determinants and impacts of the infection [6–
9]. All the published studies depict malaria in Colombia as the disease of the poorest people liv-
ing in rural areas. However, only one study offered estimates of malaria costs to families [6],
while to date, no published study has assessed the socio-economic burden of MiP in the
country.
The socio-economic aspects of disease are influenced by the characteristics of the health
system. This is particularly true for Colombia where the health system has been under continu-
ous reform for the past 25 years. Major reforms were undertaken in 1993 with the aim of
increasing health system efficiency and access to healthcare, which was very skewed towards
formal workers and left informal workers, a large proportion of the active population, unpro-
tected [10]. Under a managed competition model, the reform created two schemes, contribu-
tory and subsidised: the former targeting formal employees and people able to pay, financed
by mandatory contribution; the latter targeting people with no ability to pay, funded by the
contributory scheme and by other sources such as general taxation. Eligibility for the subsi-
dised regimen is determined through a socio-economic index called SISBEN (Sistema de Iden-
tificación de Beneficiarios; Beneficiaries Identification System) that classifies the population into
six strata based on several socio-economic indicators [11]. The lowest two strata (the poorest)
are eligible for the subsidised scheme and patients pay either nothing or a small fee for the
healthcare they receive.
Although the 1993 reform effectively increased health insurance coverage, there were dis-
cordant views on the existence of pockets of inequity the reform may have left: according to
some researchers the increase in insurance coverage did not completely translate into health-
care coverage [12–14]. Recently, under the principle of the universal right to health, citizens in
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search of (expensive) health interventions denied by the private insurers have brought legal
action (tutelas) to the Constitutional Court. Denied health services were finally funded by the
Governmental Solidarity and Guarantee Fund (Fosyga) leading to sharp increases in public
expenditure, to the extent that a recent government decree declared a “social emergency” due
to a health financing crisis [15, 16].
Some studies have assessed the regressivity or progressivity of the Colombian health financ-
ing system but still little information is available on the out-of-pocket expenditures incurred,
particularly in non-urban areas, among communities whose main activity is agriculture or
livestock [17].
In addition, armed conflict in certain rural areas has led to additional challenges for health-
care provision with women and ethnic minorities being at highest risk [18, 19]. To address this,
a series of public health interventions have targeted women of ethnic minorities living in rural
conflict areas which are often also malaria endemic areas [20]. Living in rural and conflict-
affected areas has been found to be a risk factor for catastrophic expenditures in Colombia [21].
According to the National Public Health Plan, malaria in Colombia is a “disease of public
health interest” and all the interventions, including both prevention and treatment, are free of
charge to the population, irrespective of health scheme affiliation [22]. However, despite zero
medical costs, patients still incur non-medical expenses, such as transportation, and indirect
costs, such as the value of time lost because of the illness.
The aim of this study was to estimate the costs associated with MiP in a rural area of the
Cordoba department, Northern Colombia, the area with the highest malaria burden in the
country [23–25]. At the time of the study, the area was characterized by armed conflict and
high vulnerability of ethnic minorities.
Methods
Ethics statement
This study was conducted in the context of the PregVax study. This was a health-facility based
cohort study aimed to estimate the burden of P. vivax infection in pregnancy in five endemic
countries, including Colombia. The ethics statement for PregVax is published elsewhere [26].
In addition, the economic study (ECO_PregVax) was approved by the Ethics Committee of
the Hospital Clinic of Barcelona, Spain.
All adult subjects provided written informed consent prior to participating in ECO_Preg-
Vax and, if younger than eighteen years of age, a parent or guardian provided written
informed consent on the child’s behalf.
Study area
This study was carried out in the municipality of Tierralta, department of Cordoba, a malaria
endemic area of the Colombian territory [23].
The municipality has an area of nearly 5,000 km2 with about 90,000 inhabitants, 44.4% of
whom live in rural areas, 55.6% in urban or semi-urban areas, and about 2% of the population
is indigenous. The indigenous population Embera Katı´o used to live in a protected area located
on the high basin of the Sinu´ river, administratively pertaining partly to the municipality of
Tierralta and partly to Ituango (Antioquia department). Due to both the construction of a
hydroelectric power plant that came into operation in the year 2000 and to the armed conflict,
the Embera Katı´o were forced to spread all over the municipality.
The main economic activities within the municipality are cattle farming, agriculture, log-
ging and fishing. The Gross Domestic Product per capita of Cordoba department for the year
2014 was about 3,900 US$ [27].
Patients’ costs of malaria in pregnancy in Colombia
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0006431 May 2, 2018 3 / 13
According to the national public health surveillance system, in 2010, out of a total of
117,108 malaria cases reported in Colombia, more than 20,000 (17.2%) were registered in Co´r-
doba and most of them (over 14,000) were due to P. vivax. Of the cases reported in Cordoba,
29 were in pregnant women [23]. In a village of the municipality of Tierralta, the prevalence of
Plasmodium spp. infection was 17.9% (38/212; 95% CI: 12.5–23.3%) [24]. The annual parasite
index (API) recorded between 2008 and 2012, was of 44.0 cases/1,000 habitants. Based on this,
Tierralta was considered as a high risk malaria area in comparison with two other endemic
areas of the country, namely Buenaventura (Valle del Cauca) and Tumaco (Nariño), with API
of 6.0 cases/1,000 habitants and 7.7 cases/1,000 habitants, respectively [25].
In Tierralta malaria and respiratory diseases are perceived as the most common health prob-
lems in the population. The lack of environmental interventions is recognized as the major
cause of malaria [28]. In a knowledge, attitudes and practices study undertaken in three regions
(Tierralta, Buenaventura and Tumaco) it was observed that most of the population uses insecti-
cide-treated nets (ITNs) to protect themselves from malaria, but over 75% of the people in Tier-
ralta do not use any tool or strategy to prevent malaria transmission outdoors [25].
Data were collected in the catchment area of San Jose´ hospital, a public primary level health
facility offering a range of services, including outpatients, immunization, antenatal care, labo-
ratory, pharmacy, dentistry, radiology services, emergencies and inpatients (delivery, pediatric
and adults). San Jose´ hospital directly administers 16 aid posts spread across the municipality
where a medical doctor attends patients for a few hours every week. Aid posts help increase
access to healthcare considering that traveling to the hospital from the villages takes up to 8
hours by combined transportation (usually motorbike plus boat) and the journey may include
crossing the Sinu´ river.
Study design
The PregVax study enrolled 2,043 pregnant women at the antenatal clinic of the San Jose´ hos-
pital between April 2009 and June 2011 and followed them up until delivery. Prevalence of
MiP by microscopy was 1.2% detected either at ANC follow up visits or at out- or in-patient
wards during the study period [26].
Between July and August 2011 a subset of women enrolled in the main study and diagnosed
with any Plasmodium species infection either during pregnancy or during post-partum, were
invited to participate in this economic study. As many women as was feasible, given the condi-
tions of insecurity in the area, were reached and interviewed at their homes. After written
informed consent was given, a questionnaire was administered by a trained fieldworker. We
collected personal information, time lost because of the illness, data on use and costs for the
treatment and prevention (bed net, skin repellent, insecticide) associated with MiP, including
direct (medical and non-medical) costs incurred at the health facility. Women were asked
about any previous treatments sought for the symptoms associated with the same malaria epi-
sode. Characteristics of women included in this study were compared with those of women
enrolled in the epidemiological study but not enrolled in the economic study (both malaria
infected and non-infected).
Data analysis
The data analysis and presentation of results were similar to a previous study carried out in
Brazil [5]: direct costs (financial costs) were broken down into medical, transportation and
other costs (food, phone calls, etc.). Indirect costs were calculated by multiplying reported
time lost by the legal minimum wage in force in Colombia in the year 2012 (Colombian pesos
$566,700, monthly, corresponding to US$ 307) [29]. The exchange rate was 1,848.14
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Colombian pesos to the dollar [30]. Patient costs incurred at the San Jose hospital, as well as
for any treatment sought earlier for the same episode, were calculated.
Due to the skewness of the distribution, the median and the interquartile range (IQR) were
used to report cost estimates. Mean values are also shown to provide a comprehensive descrip-
tion of cost distributions. Bootstrap simulation with 1000 replications was carried out to
resolve distribution skewness [31, 32].
The place of residence of each study woman (neighbourhood) was located on digital maps
and distance to the health facility was calculated linearly, due to the impossibility of tracing the
itinerary women may have followed to obtain treatment.
For this study, women were approached only once. However, some women experienced
more than one malaria episode during the follow-up period. To produce an estimate of the
total cost of MiP, the database generated was merged with the data from the main epidemio-
logical study. For the women with more than one episode, the cost estimated for one episode
was multiplied by N episodes, assuming that cost per episode was constant.
Data were analyzed with STATA version 12.0 (Stata/SE 12.0 Stata corporation, College Sta-
tion, TX, USA).
Results
A total of 69 women enrolled in the main epidemiological study had a malaria infection identified
either by microscopy or by PCR during pregnancy and/or at delivery. Of these, 27 were included
in this economic study. Additionally, 13 women from the main study who had malaria post-par-
tum were also enrolled for a total of 40 women. There were no statistically significant differences
in terms of age and ethnic group between the 40 women included in this economic study and the
pregnant women with malaria from the main study who were not involved in this evaluation
(N = 29): (age: t = 0.0778, Pr (¦T¦> ¦t¦ = 0.9382); ethnic group: Pearson chi2 (2) = 0.2119, Pr
0.899). Similarly, age and ethnic group differences were not significantly different between the 40
study women and those from the main study who were not included (N = 2003): (age: t = -1.3029,
Pr (¦T¦> ¦t¦ = 0.1928; ethnic group: Pearson chi2 (2) = 1.1488, Pr 0.886).
Table 1 shows that most of the 40 study women were aged between 20 and 29 years (47.5%)
but many were below 20 years (35%) and a few were 30 years old or more (17.5%). The major-
ity had already one to three children (52.5%). The great majority were common-law wives
(92.5%). Most of the women lived in the rural areas (72.5%) and all of them declared their
main activities to be household activities and child-care.
Only one woman in this sample was enrolled in the contributory regimen while the remain-
ing 39 were either part of the subsidised (1st level) or not yet assigned to the subsidised scheme
but already assessed not to have ability to pay.
Most of the study women were affiliated to EMDI Salud, one of the main private not-for
profit organizations managing subsidized health care in the department. Interestingly, 8
women were affiliated to Manexka, a health promoting entity (entidad promotora de salud—
EPS) for indigenous population, highlighting that these 8 women belonged to the Embera
Katı´o ethnic group.
Seventy percent of malaria cases were due to P.vivax and the remaining to P. falciparum
(Table 2) [33]. Most cases were outpatients (67.5%). Bed nets (either insecticide treated or
not), the only type of malaria preventative measure used, were reported by 26 women. Most
women reached the hospital by motor transportation (82.5%) and some women took more
than one type of transportation (boat plus something else). For most women (82%) it took up
to two hours to reach the health facility, but for some the trip was longer (2–5 hours) and for
one woman the journey lasted 48 hours (by animal transportation).
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The place of residence of 39 women was represented on a map. One woman’s residence was
not identified due to insufficient information. Median distance, estimated for 33 women, was
of 14.28 km (IQR 17.33) (Fig 1). This is likely to be an underestimate as six women, despite
being depicted on the map in areas far-away from the health facility (e.g. around Crucito),
were not included in the distance estimate due to imprecise information: they were only able
to provide the names of geographically spread neighbourhoods. Twelve women lived in town
while the remaining were either far or very far from the health facility and some had to cross
the river twice to reach a health consultation.
Outpatient costs
Median prevention costs (all for bed nets), were US$ 0 (IQR 8.12). Only 14 women spent a
positive amount to acquire a bed net (possibly because these were distributed for free either by
the government or by non-governmental institutions) and 26 (65%) women declared they had
slept under a bed net the night before the interview (Table 3). Only 25% of the interviewed
women had sought previous treatment and the cost incurred was negligible (mean US$ 0.88,
with a median and IQR of 0).
Table 1. Baseline characteristics of study subjects (N = 40).
N %
Age group
15–19 14 35
20–29 19 47.5
30–39 7 17.5
Marital Status
Single 2 5
Common-law wife 37 92.5
Married 1 2.5
Living a´rea
Semi-urban 11 27.5
Rural 29 72.5
Number of children (excluding the current one)
0 15 37.5
1 to 3 21 52.5
4 to 5 4 10
Main activity
Household activities/childcare 40 100
Health system regimen
Subsidised level 1 33 82.5
Beneficiaries identification system—Sistema de identificacio´n de beneficiarios (SISBEN) 6 15
Contributory 1 2.5
Health promotion entity—entidad promotora de salud (EPS)
CAPRECOM 4 12
EMDIS 21 62
MANEXKA 8 23
SALUCOOP 1 3
This information is reported from the 34 women not subscribed to SISBEN regimen
https://doi.org/10.1371/journal.pntd.0006431.t001
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Transportation was a substantial source of cost, US$ 12.99 (IQR 23.80) and so were indirect
costs of US$ 7.29 (IQR 10.55) at the health facility or US$ 7.29 (IQR 25.27) if the whole episode
was considered. Estimation using a bootstrap with 1000 replications led to similar results.
Inpatient costs
Cost of prevention and previous treatment had both median and IQR equal to 0; the mean val-
ues were US$ 2.53 and 1.87, respectively (Table 3). Transportation costs were US$ 10.82 (IQR
17.32). Indirect costs at the health facility were US$ 9.11 (IQR 3.64) or 17.31 (IQR 18.22) when
the whole clinical episode was considered. Total costs at the health facility were US$ 26.65
(IQR 24.94) or 54.33 (IQR 49.09) for the whole clinical episode. Bootstrapping the estimates
only slightly reduced the mean values.
Women who experienced two clinical episodes incurred costs ranging from US$ 18.91 to
US$ 108.66 (Table 4). Of the 5 women who had more than one episode, two had two P. falcipa-
rum infections, two had one P. vivax episode and one had a P. vivax and a P. falciparum
infection.
Discussion
Although malaria control interventions are free of charge to users in Colombia, the economic
costs incurred by pregnant women in the study were substantial. Total median costs associated
with inpatient treatment of a whole malaria episode (US$ 54.33) represented the 18% of the
Table 2. Characteristics of malaria episodes (N = 40).
N %
Type of malaria episodes (Plasmodium species)
P. vivax 28 70
P. falciparum 12 30
Type of contact with health facility
Outpatient 27 67.5
Inpatient 13 32.5
Malaria prevention tools used
Bed net 26 65
No specific prevention tools 14 35
Transportation to the health facilitya
Animal transportation 1 2.6
Motor transportation 32 82
Combined transportation 6 15.4
Time taken to reach health facility (Minutes)
15–120 33 82.5
121–300 6 15
>300 (precisely 2880 minutes = 48h) 1 2.5
Median IQR
Distance from health facilityb (Km) N = 33 14.28 17.33
Duration of clinical symptoms (days) 5 4.5
Number of nights admitted if inpatient (N = 13) 3 2
a One observation was missing on type of transportation to the health facility, despite reporting transportation cost
>0
b maximum distance was 38 km.
https://doi.org/10.1371/journal.pntd.0006431.t002
Patients’ costs of malaria in pregnancy in Colombia
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0006431 May 2, 2018 7 / 13
Fig 1. Residence of women included in the study. Red circles: Plasmodium falciparum malaria cases; Blue circles:
Plasmodium vivax cases. Purple marker: San Jose´ hospital.
https://doi.org/10.1371/journal.pntd.0006431.g001
Table 3. Costs associated with malaria incurred by the pregnant women (US$ 2011).
Outpatients N = 27 Inpatients N = 13
P. vivax = 24; P.
Falciparum = 3
P. vivax = 24; P.
Falciparum = 3
Mean Median IQRa Mean Median IQRa
Prevention costs (N = 26 declared they slept under bed net last night) 3.75 0.00 8.12 2.53 0.00 0.00
Costs of previous symptomatic treatment sought (N = 10 sought previous treatment at a health centre) 0.40 0.00 0.00 1.87 0.00 0.00
Transportation costs to the health facility 16.07 12.99 23.80 12.82 10.82 17.32
Other costs at the health facilityb 0.02 0.00 0.00 0.00 0.00 0.00
Medical costs for treatment at the health facilityc 0.00 0.00 0.00 0.00 0.00 0.00
Indirect costs at this health facilityd 9.13 7.29 3.64 10.55 9.11 3.64
Indirect costs whole episode (including previous symptomatic treatments)e 11.15 7.29 6.37 25.27 17.31 18.22
Total costs per episode at the health facilityf 18.19 16.29 21.64 27.54 26.65 24.94
Total costs whole episode (including previous symptomatic treatments)g 29.75 28.93 20.39 54.68 54.33 49.09
Bootstrap analysis (bootstrap based on 1000 replications)
Prevention costs 3.53 0.00 8.12 2.38 0 0
Total costs per episode at the health facility 18.00 16.28 21.64 27.66 26.65 24.94
Total costs whole episode (including previous symptomatic treatments) 29.42 28.93 20.39 56.23 54.33 54.31
a Interquartile range
b These include cost of food, drink and phone calls
c These include laboratory fees and drugs not provided at the health facilities
d These include the value of time lost at the health facility and money spent to contract a substitute in the main economic activity
e These include the value of time lost during the whole pattern of treatment sought and money spent to contract a substitute in the main economic activity
f These include all costs, direct and indirect, associated with treatment incurred at the health facility
g These include all costs, direct and indirect, associated with treatment incurred at the health facility plus direct and indirect costs previously incurred for the same
sample
https://doi.org/10.1371/journal.pntd.0006431.t003
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monthly minimum salary in force in the country at the time of the study (US$ 307). Transpor-
tation costs and indirect costs (cost of time) were the largest components. The highest costs of
over US$ 100 were estimated for women who experienced two inpatient episodes.
This study cannot assess whether such high costs constitute a barrier to malaria diagnosis
and treatment as only women who actually received a (positive) malaria diagnosis were
included. However, repeated episodes requiring admission are likely to imply substantial
shocks to families’ budgets.
To our knowledge, only one previous study has estimated the costs associated with P. vivax
MiP [5]. In that study, conducted in Brazil, total costs were higher than the ones estimated
here: bootstrapped median costs were US$ 49.27 for outpatients and 240.78 for inpatients ver-
sus 28.93 and 54.33 in this study. The main driver of this difference was the time spent to reach
the health facility, which was higher in Brazil than in Colombia, and which translated into
higher indirect costs, particularly for inpatients, despite the lower value of time used for Brazil
than for Colombia (monthly value of 237 US$ for Brazil and of 307 US$ for Colombia). All
remaining parameters estimated in the two studies were similar. Even though the two health
systems are very different, malaria is considered as a disease of public health interest in both
countries, and prevention and treatment are provided free of charge to patients.
All but one women in this study belonged to the first level of the subsidised system, suggest-
ing that our sample was constituted by the poorest individuals. Although we cannot quantify
their potential impact, we can speculate that costs incurred by these women are likely to repre-
sent a significant economic burden to their limited household budgets.
Importantly, in the context of this study the challenges faced by women when seeking treat-
ment are likely to go beyond the estimated costs. Armed conflict has a detrimental impact on
healthcare both from the demand and supply sides [34]. From the patient perspective, the jour-
ney from home to the health facility is likely to be dangerous, and people seeking treatment
may have to deviate from the easiest path to avoid assaults.
In Colombia, the re-emergence of infectious diseases transmitted by vectors has been par-
ticularly important in areas with armed conflict [35]. In the “Colombian National malaria con-
trol and surveillance plan 2003–2006”, Tierralta, Co´rdoba, was defined as an area where armed
conflict has exacerbated the burden of malaria due to forced displacement of the population;
either a partial or total suspension of vector control activities; challenges of diagnosis and treat-
ment; and deterioration of the environment leading to the formation of mosquitos breeding
sites [36].
There has been a high proportion of victims of forced displacement in Tierralta, including
the Embera Katı´o people who were forced to leave for several reasons: (1) the armed conflict
for the control of the land for the production and distribution of illicit drugs; (2) the illegal
exploitation of natural resources, mainly wood and (3) the construction of the dam Urra´ I in
the year 2000 [37]. There is no census reporting the exact number of displaced people; how-
ever, it is clear that the majority of displaced families lived in poverty [38]. For those who
remained in the protected area, the construction of the dam resulted in serious constrains to
Table 4. Total costs incurred by women who experienced more than one episode during pregnancy.
Total cost (US$) Number of episodes Parasite types Outpatient/inpatient
95.21 2 P. falciparum Inpatient
108.66 2 P. falciparum + P. vivax Inpatient
64.69 2 P. falciparum Inpatient
32.57 2 P. vivax Outpatient
18.91 2 P. vivax Outpatient
https://doi.org/10.1371/journal.pntd.0006431.t004
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access to food (fish in particular) and in additional limitations on movement imposed by the
armed groups: these factors led to a substantial socio-economic collapse of that community
[38].
In our sample, nearly 25% of women were indigenous. Malaria and the costs associated
with its management are potentially only the tip of the iceberg of the problems incurred by
Embera Katı´o community, who have suffered the violation of their rights to the land, their eco-
nomic independence, education, and their culture. Currently interventions are aimed at pre-
serving the culture and the rights of this indigenous population as planned by the Plan de
Salvaguarda Etnica Pueblo Embera Katı´o del Alto Sinu´ [38].
Despite several challenges, the Colombian health system is making strong efforts to
improve access to quality health care. Colombia is not far from achieving universal health care
insurance: healthcare out-of-pocket expenditures have decreased consistently, and the popula-
tion reports fewer unmet health needs and greater satisfaction with healthcare services follow-
ing the 1993 reforms [39]. As in any context, the last mile is the most difficult to cover and the
area where this study was conducted encompasses all main possible challenges: malaria
endemicity, armed conflict, rural areas and minorities.
Importantly, the peace process in Colombia, which started in 2012 with negotiations
between the leaders of the guerilla and the government and having its climax in August 2016
with the cease-fire and end of hostilities, should have a positive impact also on the health sys-
tem and on access to health services in conflict areas [40].
This study has one main limitation. Some women were interviewed several months (up to a
maximum of 9) after experiencing the malaria episode, which is likely to have resulted in recall
bias in our estimates. Recall bias in self-reported expenditure has been described to translate
into either underestimation or overestimation [41]. In this study, as questions were focused on
costs incurred on a specific episode and not on recurrent expenditures, estimates are more
likely to be underestimated as affected by “forgetting”. For this reason, the economic costs
reported in this study should be interpreted as a lower bound of the real economic cost associ-
ated with MiP. In addition, women were interviewed only once limiting the possibility of esti-
mating more precisely the whole cost associated with malaria during pregnancy and post-
partum.
A few studies have explored the economics of malaria in Colombia. In 2006, costs of
malaria treatment were estimated as part of the cost-effectiveness analysis of two alternative
strategies for malaria control [7]. One strategy was constituted by the activities of the National
Programme, the other by the integration of an educational strategy, the “Integrated Alterna-
tive” (IA) into the national program in Buenaventura on the Pacific coast of Colombia. Aver-
age household malaria treatment cost (including direct and indirect cost) in the area where the
National Programme was implemented was US$36.2 and US$28.4 in the IA area (1998
figures).
Malaria incidence appeared to be associated with income and with occupational status in
Colombia in a study that tested Becker’s human capital theory and its further developments by
Popkin and Schutz [8]. An in-depth study estimated the average cost per malaria case in Santa
Cruz (rio Naya, Colombia) as US$17.30, over 90% of which were indirect costs. The loss corre-
sponded to the value of 5.6 days of work paid at the minimum monthly wage (year 1986) [6].
Finally, labour reallocation within the family was assessed to be the most significant economic
consequence of malaria, with women substituting for men in the fields when men are affected
by the disease [9].
Despite the valuable information existing on socio-economic aspects of malaria in Colom-
bia, no study has examined MiP. The present study fills this gap by estimating the economic
burden of MiP that can inform malaria elimination initiatives in Colombia [42].
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